NASDAQ:FBLG FibroBiologics (FBLG) Stock Price, News & Analysis $1.57 -0.01 (-0.63%) (As of 10:29 AM ET) Add Compare Share Share Today's Range$1.56▼$1.6950-Day Range$1.11▼$7.1852-Week Range$1.08▼$55.00Volume38,509 shsAverage Volume188,593 shsMarket Capitalization$56.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get FibroBiologics alerts: Email Address FibroBiologics MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy2.40% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.50Based on 6 Articles This WeekInsider TradingAcquiring Shares$35,235 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.47) to ($0.29) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.72 out of 5 starsMedical Sector826th out of 924 stocksPharmaceutical Preparations Industry386th out of 426 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for FibroBiologics.Read more about FibroBiologics' stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.40% of the float of FibroBiologics has been sold short.Short Interest Ratio / Days to CoverFibroBiologics has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in FibroBiologics has recently decreased by 2.95%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldFibroBiologics does not currently pay a dividend.Dividend GrowthFibroBiologics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FBLG. Previous Next 2.5 News and Social Media Coverage News SentimentFibroBiologics has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for FibroBiologics this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for FBLG on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.MarketBeat Follows6 people have added FibroBiologics to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, FibroBiologics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $35,235.00 in company stock and sold $0.00 in company stock.Read more about FibroBiologics' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for FibroBiologics are expected to grow in the coming year, from ($0.47) to ($0.29) per share.Price to Book Value per Share RatioFibroBiologics has a P/B Ratio of 39.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about FibroBiologics' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Darwin2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] About FibroBiologics Stock (NASDAQ:FBLG)FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.Read More FBLG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FBLG Stock News HeadlinesAugust 13, 2024 | insidertrades.comFibroBiologics, Inc. (NASDAQ:FBLG) CEO Purchases $16,235.00 in StockAugust 13, 2024 | insidertrades.comFibroBiologics, Inc. (NASDAQ:FBLG) Insider Hamid Khoja Acquires 10,000 SharesAugust 22, 2024 | Crypto 101 Media (Ad)Massive Crypto Selloff = Historic OpportunityStocks recently suffered the worst 1-day loss since 2022… Cryptos got hammered as well…But here's the fact everyone is missing… As of this writing, Bitcoin is still up 28% year to date…And it's up 84% in the last year. August 20 at 9:31 AM | globenewswire.comFibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based TechnologyAugust 20 at 2:57 AM | americanbankingnews.comZacks Small Cap Weighs in on FibroBiologics, Inc.'s FY2024 Earnings (NASDAQ:FBLG)August 15, 2024 | finance.yahoo.comFBLG: Proof-of-Concept Data for Artificial Thymus Technology…August 13, 2024 | americanbankingnews.comFibroBiologics, Inc. (NASDAQ:FBLG) CEO Pete O'heeron Purchases 8,500 SharesAugust 7, 2024 | globenewswire.comFibroBiologics Files 2024 Second Quarter ReportAugust 22, 2024 | Crypto 101 Media (Ad)Massive Crypto Selloff = Historic OpportunityStocks recently suffered the worst 1-day loss since 2022… Cryptos got hammered as well…But here's the fact everyone is missing… As of this writing, Bitcoin is still up 28% year to date…And it's up 84% in the last year. July 15, 2024 | globenewswire.comFibroBiologics to Present at JonesTrading Healthcare Summit 2024June 25, 2024 | globenewswire.comFibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid TechnologyJune 13, 2024 | globenewswire.comFibroBiologics Set to Join Russell 2000® IndexJune 6, 2024 | globenewswire.comFibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024May 15, 2024 | globenewswire.comFibroBiologics Announces 2024 Annual Meeting of StockholdersMay 15, 2024 | msn.comFBLG Stock Earnings: FibroBiologics, Inc. – Common Stock Reported Results for Q1 2024May 14, 2024 | globenewswire.comFibroBiologics Files 2024 First Quarter ReportMay 7, 2024 | globenewswire.comFibroBiologics to Present at the BIO International Convention 2024April 26, 2024 | msn.comFibroBiologics files to sell 1.8M unitsSee More Headlines Receive FBLG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FibroBiologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today8/22/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:FBLG Previous SymbolNASDAQ:FBLG CUSIPN/A CIK1958777 Webwww.fibrobiologics.com Phone281-671-5150FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.64 Quick Ratio0.64 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.04 per share Price / Book39.25Miscellaneous Outstanding Shares35,719,000Free FloatN/AMarket Cap$56.08 million OptionableN/A BetaN/A 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Peter O'Heeron (Age 60)Founder, Chairman & CEO Comp: $950.72kMr. Mark C. Andersen C.F.A. (Age 52)CPA, M.B.A., Chief Financial Officer Comp: $461.88kDr. Hamid Khoja Ph.D. (Age 54)Chief Scientific Officer Comp: $423.12kMr. Ruben A. GarciaGeneral CounselKey CompetitorsscPharmaceuticalsNASDAQ:SCPHEliem TherapeuticsNASDAQ:ELYMMediWoundNASDAQ:MDWD23andMeNASDAQ:MERezoluteNASDAQ:RZLTView All CompetitorsInsiders & InstitutionsMarshall Wace LLPSold 35,323 shares on 8/14/2024Ownership: 0.047%Pete O'heeronBought 8,500 shares on 8/12/2024Total: $16,235.00 ($1.91/share)Hamid KhojaBought 10,000 shares on 8/12/2024Total: $19,000.00 ($1.90/share)Mercer Global Advisors Inc. ADVBought 10,272 shares on 8/12/2024Ownership: 0.029%Fund Evaluation Group LLCBought 1,055,105 shares on 8/6/2024Ownership: 2.954%View All Insider TransactionsView All Institutional Transactions FBLG Stock Analysis - Frequently Asked Questions How have FBLG shares performed this year? FibroBiologics' stock was trading at $17.75 at the beginning of 2024. Since then, FBLG shares have decreased by 91.1% and is now trading at $1.58. View the best growth stocks for 2024 here. When did FibroBiologics IPO? FibroBiologics (FBLG) raised $144 million in an initial public offering on Wednesday, January 31st 2024. The company issued 4,806,226 shares at $30.00 per share. When did the company's lock-up period expire? FibroBiologics' lock-up period expired on Monday, July 29th. FibroBiologics had issued 4,806,226 shares in its initial public offering on January 31st. The total size of the offering was $144,186,780 based on an initial share price of $30.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period. Who are FibroBiologics' major shareholders? Top institutional investors of FibroBiologics include Fund Evaluation Group LLC (2.95%), Cascade Financial Partners LLC (0.88%), Transform Wealth LLC (0.37%) and Bank of New York Mellon Corp (0.19%). View institutional ownership trends. How do I buy shares of FibroBiologics? Shares of FBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FBLG) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredThis Crypto Is Set to Explode in AugustWith the 2024 Bitcoin Halving, there's a potential HUGE bull run for altcoins. While everyone's chasing the...Crypto 101 Media | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredSilver Grab of the Decade?In a groundbreaking move, J.P. Morgan now possesses the largest amount of physical silver in recorded history…...Colonial Metals | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThis One stock is all you need...What if you could ignore 99% of the stock market... And retire on just ONE ticker?Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
